Literature DB >> 33314702

Liver Transplant Recipient, Caregiver, and Provider Perceptions of Cardiovascular Disease and Related Risk Factors After Transplant.

Lisa B VanWagner1,2, Elisa Gordon3, Lindsay Adamski1, Megan Kosirog1, Amna Daud3, Daniel J Finn1, Donald M Lloyd-Jones2,4, Jane L Holl5.   

Abstract

Liver transplant recipients (LTRs) are at high risk for cardiovascular disease (CVD). We sought to characterize LTR, informal caregiver, and health care provider perceptions about CVD care after liver transplantation (LT) to inform the design of solutions to improve care. Participants included adult LTRs, their caregivers, and multispecialty health care providers recruited from an urban tertiary care network who participated in 90-minute focus groups and completed a brief survey. Focus group transcripts were analyzed using thematic analysis, and survey data were analyzed using descriptive statistics. A total of 17 LTRs, 9 caregivers, and 22 providers participated in 7 separate focus groups. Most (93.3%) LTRs and caregivers were unaware of the risk of CVD after LT. Although 54.5% of providers were confident discussing CVD risk factors with LTRs, only 36.3% were confident managing CVD risk factors in LTRs, and only 13.6% felt that CVD risk factors in their LTR patients were well controlled. Barriers to CVD care for LTRs included (1) lack of awareness of CVD risk after LT, (2) lack of confidence in an ability to provide proper CVD care to LTRs, (3) reluctance to provide CVD care without transplant provider review, and (4) complexity of communication with the multidisciplinary LTR care team about CVD care. Participant recommendations included improved education for LTRs and caregivers about CVD risk factors, electronic health record alerts for providers, clearly defined CVD care provider roles, increased use of the transplant pharmacist, and multidisciplinary provider meetings to discuss care plans for LTRs. Multiple barriers to CVD care after LT were identified, and targeted recommendations were proposed by participants. Transplant centers should integrate participants' recommendations when designing interventions to optimize CVD care for LTRs.
Copyright © 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33314702      PMCID: PMC8822904          DOI: 10.1002/lt.25973

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  25 in total

1.  Cumulative risk of cardiovascular events after orthotopic liver transplantation.

Authors:  Mazen Albeldawi; Ashish Aggarwal; Surabhi Madhwal; Jacek Cywinski; Rocio Lopez; Bijan Eghtesad; Nizar N Zein
Journal:  Liver Transpl       Date:  2012-03       Impact factor: 5.799

2.  Chronic diseases: what happens when they come in multiples?

Authors:  Susan M Smith; Tom O'Dowd
Journal:  Br J Gen Pract       Date:  2007-04       Impact factor: 5.386

3.  Social support and psychological adjustment to SARS: the mediating role of self-care self-efficacy.

Authors:  Winnie W S Mak; Rita W Law; Jean Woo; Fanny M Cheung; Dominic Lee
Journal:  Psychol Health       Date:  2009-02

4.  Effects of an individualized caregiver training intervention on self-efficacy of cancer caregivers.

Authors:  Cristina C Hendrix; Richard Landerman; Amy P Abernethy
Journal:  West J Nurs Res       Date:  2011-09-26       Impact factor: 1.967

5.  Liver transplantation and chronic disease management: Moving beyond patient and graft survival.

Authors:  Marina Serper; Sumeet K Asrani
Journal:  Am J Transplant       Date:  2020-01-10       Impact factor: 8.086

Review 6.  Keys to long-term care of the liver transplant recipient.

Authors:  Kymberly D Watt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

7.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

8.  Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.

Authors:  Lynn A Fussner; Julie K Heimbach; Chun Fan; Ross Dierkhising; Elizabeth Coss; Michael D Leise; Kymberly D Watt
Journal:  Liver Transpl       Date:  2015-07       Impact factor: 5.799

9.  Integrating Personalized Care Planning into Primary Care: a Multiple-Case Study of Early Adopting Patient-Centered Medical Homes.

Authors:  Rendelle E Bolton; Barbara G Bokhour; Timothy P Hogan; Tana M Luger; Mollie Ruben; Gemmae M Fix
Journal:  J Gen Intern Med       Date:  2019-10-24       Impact factor: 5.128

Review 10.  The Health Belief Model: a decade later.

Authors:  N K Janz; M H Becker
Journal:  Health Educ Q       Date:  1984
View more
  3 in total

Review 1.  Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.

Authors:  Manhal Izzy; Brett E Fortune; Marina Serper; Nicole Bhave; Andrew deLemos; Juan F Gallegos-Orozco; Cesar Guerrero-Miranda; Shelley Hall; Matthew E Harinstein; Maria G Karas; Michael Kriss; Nicholas Lim; Maryse Palardy; Deirdre Sawinski; Emily Schonfeld; Anil Seetharam; Pratima Sharma; Jose Tallaj; Darshana M Dadhania; Lisa B VanWagner
Journal:  Am J Transplant       Date:  2022-03-31       Impact factor: 9.369

2.  Comanagement With Nephrologist Care Is Associated With Fewer Cardiovascular Events Among Liver Transplant Recipients With Chronic Kidney Disease.

Authors:  Patrick T Campbell; Megan Kosirog; Blessing Aghaulor; Dyanna Gregory; Stewart Pine; Amna Daud; Arighno Das; Daniel J Finn; Josh Levitsky; Jane L Holl; Donald M Lloyd-Jones; Lisa B VanWagner
Journal:  Transplant Direct       Date:  2021-09-20

3.  Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients.

Authors:  Claire Harrington; Megan Kosirog; Patrick Campbell; Dyanna Gregory; Amna Daud; Josh Levitsky; Jane L Holl; Donald M Lloyd-Jones; Lisa B VanWagner
Journal:  Transplant Direct       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.